<DOC>
	<DOCNO>NCT02232984</DOCNO>
	<brief_summary>The purpose study evaluate different way program around extracardiac stimulation .</brief_summary>
	<brief_title>Quadripolar CRT-D On Currently Approved Lead SystemS</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Subject medically indicate implantation BSC DYNAGEN INOGEN X4 CRTD ( future FDA approve BSC X4 CRTD ) already implant with/scheduled receive commercially available quadripolar leave ventricular lead Subject willing capable providing informed consent participate test study visit associate investigation approve center interval define protocol Subject age 18 , legal age give inform consent specific state national law Subject know suspected sensitivity dexamethasone acetate ( DXA ) Subject enrol concurrent study , without prior approval BSC Women childbearing potential might pregnant time study enrollment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Heart Failure</keyword>
	<keyword>Cardiac Resynchronization Therapy</keyword>
	<keyword>CRT-D</keyword>
	<keyword>Quadripolar pacing</keyword>
</DOC>